The WAVE team invite healthcare professionals working across Europe to share their experience of anal cancer screening practices for women living with HIV in a short online survey.

Women living with HIV have an increased risk of HPV-related anogenital cancers including anal cancer compared to women living without HIV, however, they are often not included in screening programmes for anal cancer. A recent systematic review conducted by members of WAVE focused on screening for HPV-related anogenital cancers amongst women living with HIV in Europe. It found there is very little published data regarding anal cancer screening for this population and practices vary across the region. To contextualise these findings WAVE team Karoline Aebi-Popp, Hazal Albayak, Yvonne Gilleece, Dagny Krankowska, Deborah Konopnicki, Maria Mazzitell, Harriet Mortimer and Eva Orviz have developed an online survey inviting healthcare practitioners who work with women living with HIV across Europe to share their experiences around anal cancer screening. This survey is now available will remain open until 30 November 2024.

The aims of the survey are to provide insight into the clinical practices and protocols followed by nurses, doctors and allied healthcare professionals taking care of people with HIV across different international settings. By gathering this information, the team hope to expand what is known about anal cancer screening practices and improve European guidelines to inform best practice.

Are you a nurse, doctor or allied healthcare professional working with women living with HIV in Europe? Click here to share your experiences in this short survey before 20 December.